- Home
- SWIN vs LSB Comparison
SWIN vs LSB Comparison
Compare SWIN & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- LSB
- Stock Information
- Founded
- SWIN 2017
- LSB 2002
- Country
- SWIN Hong Kong
- LSB China
- Employees
- SWIN N/A
- LSB N/A
- Industry
- SWIN
- LSB
- Sector
- SWIN
- LSB
- Exchange
- SWIN Nasdaq
- LSB NYSE
- Market Cap
- SWIN 41.7M
- LSB 49.8M
- IPO Year
- SWIN 2023
- LSB N/A
- Fundamental
- Price
- SWIN $1.76
- LSB $2.96
- Analyst Decision
- SWIN
- LSB
- Analyst Count
- SWIN 0
- LSB 0
- Target Price
- SWIN N/A
- LSB N/A
- AVG Volume (30 Days)
- SWIN 101.5K
- LSB 22.5K
- Earning Date
- SWIN 01-03-2025
- LSB 01-21-2025
- Dividend Yield
- SWIN N/A
- LSB N/A
- EPS Growth
- SWIN N/A
- LSB N/A
- EPS
- SWIN N/A
- LSB N/A
- Revenue
- SWIN $3,437,000.00
- LSB $79,415,311.00
- Revenue This Year
- SWIN $165,742.30
- LSB $39.33
- Revenue Next Year
- SWIN $29.12
- LSB $75.61
- P/E Ratio
- SWIN N/A
- LSB N/A
- Revenue Growth
- SWIN N/A
- LSB N/A
- 52 Week Low
- SWIN $1.70
- LSB $1.88
- 52 Week High
- SWIN $72.55
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- SWIN 28.20
- LSB 55.32
- Support Level
- SWIN $1.70
- LSB $2.10
- Resistance Level
- SWIN $2.09
- LSB $2.77
- Average True Range (ATR)
- SWIN 0.18
- LSB 0.37
- MACD
- SWIN -0.05
- LSB 0.04
- Stochastic Oscillator
- SWIN 7.14
- LSB 61.40
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.